Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GCT-103 by S-Quatre for Cerebral Palsy: Likelihood of Approval
GCT-103 is under clinical development by S-Quatre and currently in Phase II for Cerebral Palsy. According to GlobalData, Phase II...